Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-037746)

Filing Details

Accession Number:: 0001140361-12-037746
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-20 15:00:44
Reporting Period:: 2012-08-16

Filing Date:: 2012-08-20
Accepted Time:: 2012-08-20 15:00:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1241821	A Michael Griffith	C/O Repligen Corporation 41 Seyon St, Bldg 1, Ste 100 Waltham MA 02453		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-16	1,600	$4.88	1,600	No	4	P	Direct
Common Stock	Acquisiton	2012-08-16	200	$4.88	1,800	No	4	P	Direct
Common Stock	Acquisiton	2012-08-16	200	$4.87	2,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$4.53	2013-05-24	2022-05-24	24,000	24,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-05-24	24,000	24,000	Direct

Footnotes

8,000 shares vest and become exercisable on each of the following dates: 5/24/2013, 5/24/2014 and 5/24/2015.